These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20863557)

  • 1. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
    Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
    Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
    Ho YC; Mi FL; Sung HW; Kuo PL
    Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency.
    Peng SF; Yang MJ; Su CJ; Chen HL; Lee PW; Wei MC; Sung HW
    Biomaterials; 2009 Mar; 30(9):1797-808. PubMed ID: 19110309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering.
    Matsusaki M; Akashi M
    Biomacromolecules; 2005; 6(6):3351-6. PubMed ID: 16283765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functional biodegradable polymer II: fibroblast growth factor-2 activities of poly(gamma-glutamic acid)-sulfonate.
    Matsusaki M; Serizawa T; Kishida A; Akashi M
    Biomacromolecules; 2005; 6(1):400-7. PubMed ID: 15638545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
    Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor.
    Ho YC; Wu SJ; Mi FL; Chiu YL; Yu SH; Panda N; Sung HW
    Bioconjug Chem; 2010 Jan; 21(1):28-38. PubMed ID: 20000719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entrapment of basic fibroblast growth factor (bFGF) in a succinylated chitosan nanoparticle delivery system and release profile.
    Butko A; Bonat Celli G; Paulson A; Ghanem A
    J Biomater Sci Polym Ed; 2016 Jul; 27(10):1045-57. PubMed ID: 27146359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity and biocompatibility of a chitosan-gamma-poly(glutamic acid) polyelectrolyte complex hydrogel.
    Tsao CT; Chang CH; Lin YY; Wu MF; Wang JL; Han JL; Hsieh KH
    Carbohydr Res; 2010 Aug; 345(12):1774-80. PubMed ID: 20598293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles formed by complexation of poly-gamma-glutamic acid with lead ions.
    Bodnár M; Kjøniksen AL; Molnár RM; Hartmann JF; Daróczi L; Nyström B; Borbély J
    J Hazard Mater; 2008 May; 153(3):1185-92. PubMed ID: 17997032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bFGF-chitosan matrices and their interactions with human dermal fibroblast cells.
    Lefler A; Ghanem A
    J Biomater Sci Polym Ed; 2009; 20(10):1335-51. PubMed ID: 19622275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparinized magnetic mesoporous silica nanoparticles as multifunctional growth factor delivery carriers.
    Wu Q; Liu C; Fan L; Shi J; Liu Z; Li R; Sun L
    Nanotechnology; 2012 Dec; 23(48):485703. PubMed ID: 23128185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
    Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
    Yoon JJ; Chung HJ; Lee HJ; Park TG
    J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis.
    Kim MS; Bhang SH; Yang HS; Rim NG; Jun I; Kim SI; Kim BS; Shin H
    Tissue Eng Part A; 2010 Oct; 16(10):2999-3010. PubMed ID: 20486788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.